# Karim Karti

> Karim Karti is the CEO of RapidAI, a deep clinical AI company whose platform is used in 2,500+ hospitals across 100+ countries for stroke, vascular, and radiology workflows. He brings 22+ years from GE Healthcare — including running its $9B imaging division — and a stint as COO of iRhythm, where he doubled revenues to $210M in 18 months. Trained as an engineer in France and a former P&G brand manager, he now leads one of the most clinically validated AI platforms in medicine, backed by 700+ published studies and 10+ million scans processed.

- **Role:** CEO at RapidAI
- **Organizations:** RapidAI, iRhythm Technologies, GE Healthcare, Procter & Gamble, MedTech Acquisition Corp., Rockley Photonics Holdings Ltd., Braid Health, Inc.
- **Nationality:** French
- **Education:** MSc in Engineering, Ecole Centrale de Lyon, Entrepreneurship Program, Ecole Superieure de Commerce de Lyon
- **Known for:** Doubled iRhythm Technologies revenues from ~$105M to $210M in 18 months as COO, Led GE Healthcare Imaging Division ($9B business) to become one of GE's fastest-growing businesses in 2017, Expanded RapidAI to 2,500+ hospitals in 100+ countries

## Career timeline

- **1993** — Joined Procter & Gamble as Brand Manager
- **1996** — Joined GE Corporate Audit Staff
- **2000** — Joined GE Healthcare, began roles across US, Europe, Asia
- **2010s** — President & CEO, GE Healthcare Korea
- **2013** — President & CEO, GE Healthcare Growth Markets (Turkey, Central Asia, Russia, CIS, Middle East, Africa)
- **2016** — President & CEO, GE Healthcare Imaging Division - led $9B business
- **2018** — Joined iRhythm Technologies as Chief Operating Officer
- **2020** — Left iRhythm after doubling revenues to $210M in 18 months
- **2022** — Appointed CEO of RapidAI (formerly iSchemaView) on January 31
- **2023** — RapidAI closes $75M Series C funding round (July 2023)
- **2025** — RapidAI receives five new FDA clearances for imaging modules
- **2026** — RapidAI presents 28 scientific abstracts at International Stroke Conference

## Achievements

- Doubled iRhythm Technologies revenues from ~$105M to $210M in 18 months as COO
- Led GE Healthcare Imaging Division ($9B business) to become one of GE's fastest-growing businesses in 2017
- Expanded RapidAI to 2,500+ hospitals in 100+ countries
- Oversaw 700+ published clinical studies validating RapidAI platform
- Oversaw five new FDA clearances for RapidAI imaging modules (November 2025)
- Guided RapidAI through $75M Series C funding round (July 2023, total $102.75M raised)
- Grew RapidAI platform to process 10+ million scans
- Board roles at MedTech Acquisition Corp., Rockley Photonics, and Braid Health

## Latest updates

- **2026-02** — Healthcare IT Today interview on rethinking radiology workflow resilience amid radiologist shortages and cyber threats
- **2026-01** — RapidAI presented 28 scientific abstracts at International Stroke Conference 2026, including data showing 46% better aneurysm growth detection vs. neuroradiologists alone
- **2025-11** — RapidAI received five new FDA clearances: Rapid DeltaFuse, Rapid LMVO, Rapid MLS, Rapid OH, and Rapid Aortic
- **2025-04** — Appeared on WEDI Podcast Episode 197: 'When Time is of the Essence: Leveraging AI Imaging to Support Vascular Conditions'
- **2023-07** — RapidAI closes $75M Series C funding round, bringing total raised to $102.75M

## Links

- Website: https://rapidai.com
- LinkedIn: http://www.linkedin.com/in/karim-karti-6a20503
- Twitter/X: https://twitter.com/karimkarti
- Facebook: https://facebook.com/pg/rapidai/

---

Profile page: https://yespress.io/karim-karti
Published by YesPress — https://yespress.io
Last updated: 2026-05-26